Biodexa Pharmaceuticals (BDRX) announced the appointment of Precision for Medicine as the clinical research organization, CRO, to conduct the ...
A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP ...
Novotech Releases 2025 Report Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies ...
Q4 2024 Earnings Call Transcript March 5, 2025 Ocugen, Inc. reports earnings inline with expectations. Reported EPS is $-0.05 ...
CERo Therapeutics (CERO) announces the execution of an agreement with contract research organization CellCarta to manage translational assays ...
Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced a new ...
The AD/PDâ„¢ Conference is an annual event attracting leading medical and scientific professionals from around the world, ...
2h
AZoLifeSciences on MSNMinoryx Announces Dosing of the First Patient with Leriglitazone in the Phase 2a Study in Rett Syndrome (TREE Study)Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system ...
First-in-human global studies initiated for ZW191, an antibody-drug conjugate (ADC) engineered to target folate receptor-? (FR?) and ZW171, a bispecific 2 + 1 T cell engager (TCE) targeting mesothelin ...
A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...
Posters presented at the Association of Cancer Care Centers opening session covered initiatives to boost clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results